Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysis

PURPOSE: The aim of the study was to evaluate the efficacy and safety of combining sorafenib with chemotherapy in patients with human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. METHODS: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, American Society...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jie, Tian, Chun-Xiang, Yu, Miao, Lv, Qing, Cheng, Nan-Sheng, Wang, Zu, Wu, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988344/
https://www.ncbi.nlm.nih.gov/pubmed/24744799
http://dx.doi.org/10.4048/jbc.2014.17.1.61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988344/
https://www.ncbi.nlm.nih.gov/pubmed/24744799
http://dx.doi.org/10.4048/jbc.2014.17.1.61

Ejemplares similares